195 related articles for article (PubMed ID: 11922404)
1. Assessing the impact of migraine.
Dowson AJ
Curr Med Res Opin; 2001; 17(4):298-309. PubMed ID: 11922404
[TBL] [Abstract][Full Text] [Related]
2. Botulinum toxin type A as migraine preventive treatment in patients previously failing oral prophylactic treatment due to compliance issues.
Cady R; Schreiber C
Headache; 2008 Jun; 48(6):900-13. PubMed ID: 18047501
[TBL] [Abstract][Full Text] [Related]
3. Recognition and management of migraine in primary care: influence of functional impact measured by the headache impact test (HIT).
De Diego EV; Lanteri-Minet M
Cephalalgia; 2005 Mar; 25(3):184-90. PubMed ID: 15689193
[TBL] [Abstract][Full Text] [Related]
4. [The application of migraine disability assessment questionnaire (MIDAS)].
Hung PH; Fuh JL; Wang SJ
Acta Neurol Taiwan; 2006 Mar; 15(1):43-8. PubMed ID: 16599285
[TBL] [Abstract][Full Text] [Related]
5. Clinical utility of an instrument assessing migraine disability: the Migraine Disability Assessment (MIDAS) questionnaire.
Lipton RB; Stewart WF; Sawyer J; Edmeads JG
Headache; 2001 Oct; 41(9):854-61. PubMed ID: 11703471
[TBL] [Abstract][Full Text] [Related]
6. HIT-6 and MIDAS as measures of headache disability in a headache referral population.
Sauro KM; Rose MS; Becker WJ; Christie SN; Giammarco R; Mackie GF; Eloff AG; Gawel MJ
Headache; 2010 Mar; 50(3):383-95. PubMed ID: 19817883
[TBL] [Abstract][Full Text] [Related]
7. Identifying patients who require a change in their current acute migraine treatment: the Migraine Assessment of Current Therapy (Migraine-ACT) questionnaire.
Dowson AJ; Tepper SJ; Baos V; Baudet F; D'Amico D; Kilminster S
Curr Med Res Opin; 2004 Jul; 20(7):1125-35. PubMed ID: 15265257
[TBL] [Abstract][Full Text] [Related]
8. Validity and reliability of the Turkish Migraine Disability Assessment (MIDAS) questionnaire.
Ertaş M; Siva A; Dalkara T; Uzuner N; Dora B; Inan L; Idiman F; Sarica Y; Selçuki D; Sirin H; Oğuzhanoğlu A; Irkeç C; Ozmenoğlu M; Ozbenli T; Oztürk M; Saip S; Neyal M; Zarifoğlu M;
Headache; 2004 Sep; 44(8):786-93. PubMed ID: 15330825
[TBL] [Abstract][Full Text] [Related]
9. Disability in young patients suffering from primary headaches.
Grazzi L; D'Amico D; Usai S; Solari A; Bussone G
Neurol Sci; 2004 Oct; 25 Suppl 3():S111-2. PubMed ID: 15549516
[TBL] [Abstract][Full Text] [Related]
10. MIDAS and HIT-6 French translation: reliability and correlation between tests.
Magnoux E; Freeman MA; Zlotnik G
Cephalalgia; 2008 Jan; 28(1):26-34. PubMed ID: 17970768
[TBL] [Abstract][Full Text] [Related]
11. MIDAS questionnaire modification for a new MIDAS junior questionnaire: a clinical experience at the Neurological Institute "C. Besta".
Grazzi L
Neurol Sci; 2004 Oct; 25 Suppl 3():S261-2. PubMed ID: 15549553
[TBL] [Abstract][Full Text] [Related]
12. Disability and quality of life in different primary headaches: results from Italian studies.
Bussone G; Usai S; Grazzi L; Rigamonti A; Solari A; D'Amico D
Neurol Sci; 2004 Oct; 25 Suppl 3():S105-7. PubMed ID: 15549514
[TBL] [Abstract][Full Text] [Related]
13. Measuring responses to therapy in headache patients: new and traditional end-points.
D'Amico D; Grazzi L; Usai S; Rigamonti A; Solari A; Bussone G;
Neurol Sci; 2004 Oct; 25 Suppl 3():S108-10. PubMed ID: 15549515
[TBL] [Abstract][Full Text] [Related]
14. Validity and reliability of Turkish translation of Migraine Disability Assessment (MIDAS) questionnaire in patients with migraine.
Gedikoglu U; Coskun O; Inan LE; Ucler S; Tunc T; Emre U
Cephalalgia; 2005 Jun; 25(6):452-6. PubMed ID: 15910570
[TBL] [Abstract][Full Text] [Related]
15. Validity and reliability of the Migraine-Treatment Optimization Questionnaire.
Lipton RB; Kolodner K; Bigal ME; Valade D; Láinez MJ; Pascual J; Gendolla A; Bussone G; Islam N; Albert K; Parsons B
Cephalalgia; 2009 Jul; 29(7):751-9. PubMed ID: 19239676
[TBL] [Abstract][Full Text] [Related]
16. Migraine heterogeneity. Disability, pain intensity, and attack frequency and duration.
Stewart WF; Shechter A; Lipton RB
Neurology; 1994 Jun; 44(6 Suppl 4):S24-39. PubMed ID: 8008223
[TBL] [Abstract][Full Text] [Related]
17. Comparison of Short Form-36 and Migraine Disability Assessment questionnaire in patients with migraine.
Fuh JL; Wang SJ
Clin J Pain; 2006; 22(6):564-8. PubMed ID: 16788344
[TBL] [Abstract][Full Text] [Related]
18. Chronic migraine with medication overuse: treatment outcome and disability at 3 years follow-up.
Usai S; Grazzi L; Andrasik F; D'Amico D; Rigamonti A; Bussone G
Neurol Sci; 2004 Oct; 25 Suppl 3():S272-3. PubMed ID: 15549557
[TBL] [Abstract][Full Text] [Related]
19. [Disability and quality of life in patients with migraine: determining factors].
Fernández-Concepción O; Canuet-Delis L
Rev Neurol; 2003 Jun 16-30; 36(12):1105-12. PubMed ID: 12833226
[TBL] [Abstract][Full Text] [Related]
20. Recognition and therapeutic management of migraine in 2004, in France: results of FRAMIG 3, a French nationwide population-based survey.
Lucas C; Géraud G; Valade D; Chautard MH; Lantéri-Minet M
Headache; 2006 May; 46(5):715-25. PubMed ID: 16643573
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
